2ACW image
Deposition Date 2005-07-19
Release Date 2005-11-15
Last Version Date 2024-02-14
Entry Detail
PDB ID:
2ACW
Keywords:
Title:
Crystal Structure of Medicago truncatula UGT71G1 complexed with UDP-glucose
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.28
R-Value Work:
0.20
R-Value Observed:
0.25
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:triterpene UDP-glucosyl transferase UGT71G1
Gene (Uniprot):11410948
Chain IDs:A, B
Chain Length:465
Number of Molecules:2
Biological Source:Medicago truncatula
Ligand Molecules
Primary Citation
Crystal Structures of a Multifunctional Triterpene/Flavonoid Glycosyltransferase from Medicago truncatula.
Plant Cell 17 3141 3154 (2005)
PMID: 16214900 DOI: 10.1105/tpc.105.035055

Abstact

Glycosylation is a ubiquitous reaction controlling the bioactivity and storage of plant natural products. Glycosylation of small molecules is catalyzed by a superfamily of glycosyltransferases (GTs) in most plant species studied to date. We present crystal structures of the UDP flavonoid/triterpene GT UGT71G1 from Medicago truncatula bound to UDP or UDP-glucose. The structures reveal the key residues involved in the recognition of donor substrate and, by comparison with other GT structures, suggest His-22 as the catalytic base and Asp-121 as a key residue that may assist deprotonation of the acceptor by forming an electron transfer chain with the catalytic base. Mutagenesis confirmed the roles of these key residues in donor substrate binding and enzyme activity. Our results provide an initial structural basis for understanding the complex substrate specificity and regiospecificity underlying the glycosylation of plant natural products and other small molecules. This information will direct future attempts to engineer bioactive compounds in crop plants to improve plant, animal, and human health and to facilitate the rational design of GTs to improve the storage and stability of novel engineered bioactive compounds.

Legend

Protein

Chemical

Disease

Primary Citation of related structures